These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 782963)
21. Assessment of resistance to influenza virus infection in animal models. Potter CW; McLaren C; Jennings R Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574 [TBL] [Abstract][Full Text] [Related]
22. A clinical trial of WRL 105 strain live attenuated influenza vaccine comparing four methods of intranasal vaccination. White WG; Freestone DS; Bowker CH; Barnes GM; Letley E; Ferris RD Dev Biol Stand; 1976; 33():202-6. PubMed ID: 782970 [TBL] [Abstract][Full Text] [Related]
23. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine. Greenbaum E; Engelhard D; Levy R; Schlezinger M; Morag A; Zakay-Rones Z Vaccine; 2004 Jun; 22(20):2566-77. PubMed ID: 15193382 [TBL] [Abstract][Full Text] [Related]
33. [Vaccination of children against influenza]. Pressler K; Sattler HJ; Schöck V Z Kinderheilkd; 1975; 118(4):265-9. PubMed ID: 1130119 [TBL] [Abstract][Full Text] [Related]
34. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults. Keitel WA; Cate TR; Nino D; Huggins LL; Six HR; Quarles JM; Couch RB J Infect Dis; 2001 Jan; 183(2):329-332. PubMed ID: 11110645 [TBL] [Abstract][Full Text] [Related]
35. Response of ferrets to infection with a live attenuated influenza virus and to subsequent heterologous challenge. Delem A Dev Biol Stand; 1976; 33():226-33. PubMed ID: 955269 [TBL] [Abstract][Full Text] [Related]
36. HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16. Spencer MJ; Cherry JD; Terasaki PI N Engl J Med; 1976 Jan; 294(1):13-6. PubMed ID: 1105178 [TBL] [Abstract][Full Text] [Related]
37. Protective efficacy of live influenza vaccines. Its assessment in field and experimental conditions. Jovanovic D; Georges-Delvaux AM; Delem A Dev Biol Stand; 1979; 43():241-5. PubMed ID: 391630 [TBL] [Abstract][Full Text] [Related]
38. Influenza vaccination by nasal route in a semi-closed community. Steiner N; Petrescu A; Teodosiu O; Mihail A; Mihăilescu M; Steiner G; Berca C; Călina A; Soare C Virologie; 1980; 31(2):117-20. PubMed ID: 7405010 [No Abstract] [Full Text] [Related]
39. An evaluation of influenza immunization: influence of route of administration and vaccine strain. Waldman RH; Bond JO; Levitt LP; Hartwig EC; Prather EC; Baratta RL; Neill JS; Small PA Bull World Health Organ; 1969; 41(3):543-8. PubMed ID: 4908340 [TBL] [Abstract][Full Text] [Related]
40. Bivalent influenza vaccination with inactivated vaccines administered by nasal or oral route. Petrescu A; Mihail A; Popescu A; Cojiţă M; Sternberg I; Steiner N; Hondor C Virologie; 1976; 27(1):41-5. PubMed ID: 941402 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]